X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DISHMAN PHARMA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DISHMAN PHARMA CADILA HEALTHCARE/
DISHMAN PHARMA
 
P/E (TTM) x 34.8 25.1 138.8% View Chart
P/BV x 9.0 3.3 268.1% View Chart
Dividend Yield % 0.7 0.7 102.7%  

Financials

 CADILA HEALTHCARE   DISHMAN PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
DISHMAN PHARMA
Mar-16
CADILA HEALTHCARE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs454374 121.4%   
Low Rs305129 236.2%   
Sales per share (Unadj.) Rs96.1197.8 48.6%  
Earnings per share (Unadj.) Rs14.921.2 70.1%  
Cash flow per share (Unadj.) Rs17.834.7 51.3%  
Dividends per share (Unadj.) Rs3.202.00 160.0%  
Dividend yield (eoy) %0.80.8 106.1%  
Book value per share (Unadj.) Rs52.3179.9 29.1%  
Shares outstanding (eoy) m1,023.7480.69 1,268.7%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.91.3 310.4%   
Avg P/E ratio x25.511.9 215.0%  
P/CF ratio (eoy) x21.37.2 293.7%  
Price / Book Value ratio x7.31.4 518.9%  
Dividend payout %21.59.4 228.1%   
Avg Mkt Cap Rs m388,45820,306 1,913.1%   
No. of employees `00015.40.8 1,862.6%   
Total wages/salary Rs m13,3175,355 248.7%   
Avg. sales/employee Rs Th6,371.119,252.7 33.1%   
Avg. wages/employee Rs Th862.46,459.5 13.4%   
Avg. net profit/employee Rs Th986.12,064.1 47.8%   
INCOME DATA
Net Sales Rs m98,37615,961 616.4%  
Other income Rs m941265 354.6%   
Total revenues Rs m99,31716,226 612.1%   
Gross profit Rs m23,8294,103 580.7%  
Depreciation Rs m3,0221,091 277.1%   
Interest Rs m486944 51.5%   
Profit before tax Rs m21,2622,334 911.1%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m51 454.5%   
Extraordinary Inc (Exp) Rs m-250-   
Tax Rs m5,716624 916.6%   
Profit after tax Rs m15,2261,711 889.8%  
Gross profit margin %24.225.7 94.2%  
Effective tax rate %26.926.7 100.6%   
Net profit margin %15.510.7 144.4%  
BALANCE SHEET DATA
Current assets Rs m44,37611,018 402.8%   
Current liabilities Rs m34,0719,517 358.0%   
Net working cap to sales %10.59.4 111.4%  
Current ratio x1.31.2 112.5%  
Inventory Days Days54110 48.7%  
Debtors Days Days6235 179.0%  
Net fixed assets Rs m47,89616,304 293.8%   
Share capital Rs m1,024161 634.4%   
"Free" reserves Rs m48,74612,907 377.7%   
Net worth Rs m53,51914,516 368.7%   
Long term debt Rs m8,9644,189 214.0%   
Total assets Rs m100,16329,805 336.1%  
Interest coverage x44.73.5 1,289.2%   
Debt to equity ratio x0.20.3 58.0%  
Sales to assets ratio x1.00.5 183.4%   
Return on assets %15.78.9 176.1%  
Return on equity %28.411.8 241.3%  
Return on capital %34.317.5 195.6%  
Exports to sales %45.324.8 182.6%   
Imports to sales %5.93.7 158.8%   
Exports (fob) Rs m44,5373,956 1,125.8%   
Imports (cif) Rs m5,838596 979.0%   
Fx inflow Rs m44,8814,952 906.4%   
Fx outflow Rs m9,069697 1,301.5%   
Net fx Rs m35,8124,255 841.7%   
CASH FLOW
From Operations Rs m19,9382,786 715.5%  
From Investments Rs m-9,039-1,529 591.2%  
From Financial Activity Rs m-9,527-941 1,012.3%  
Net Cashflow Rs m1,372316 433.6%  

Share Holding

Indian Promoters % 74.8 61.4 121.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.7 224.3%  
FIIs % 5.9 12.7 46.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 22.1 49.8%  
Shareholders   44,069 46,261 95.3%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   GSK PHARMA  JUBILANT LIFE SCIENCES  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Red; Infosys Tanks as CEO Vishal Sikka Resigns(09:30 am)

Asian indices are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.2%, while the Hang Seng is down 0.7%. The Nikkei 225 is trading lower by 0.9%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 18, 2017 11:14 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS